Page 256 - The Netter Collection of Medical Illustrations - Integumentary System_ Volume 4 ( PDFDrive )
P. 256

References                                                                                            Integumentary System

       Zalaudek I, Hofmann-Wellenhof R, Kittler H, et al. A dual concept   Kossard S, Tan KB, Choy C. Keratoacanthoma and infundibulo-  Alikhan  A,  Kurek  L,  Feldman  SR.  The  role  of  tetracyclines  in
        of nevogenesis: theoretical considerations based on dermoscopic   cystic  squamous  cell  carcinoma.  Am  J  Dermatopathol.  2008;30:  rosacea. Am J Clin Dermatol. 2010;11:79-87.
        features  of  melanocytic  nevi.  J  Dtsch  Dermatol  Ges.  2007;5:  127-134.      Al-Mahfoudh  R,  Clark  S,  Buxton  N.  Alkaptonuria  presenting
        985-992.                                 Lansigan F, Foss FM. Current and emerging treatment strategies   with ochronotic spondyloarthropathy. Br J Neurosurg. 2008;22:
       Zarineh A, Kozovska ME, Brown WG, et al. Smooth muscle ham-  for cutaneous T-cell lymphoma. Drugs. 2010;70:273-286.  805-807.
        artoma associated with a congenital pattern of melanocytic nevus:   Liao PB. Merkel cell carcinoma. Dermatol Ther. 2008;21:447-451.  Antoniu  SA.  Targeting  the  TNF-alpha  pathway  in  sarcoidosis.
        a  case  report  and  review  of  the  literature.  J  Cutan  Pathol.   Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in   Expert Opin Ther Targets. 2010;14:21-29.
        2008;35:83-86.                            patients with metastatic carcinoma: a retrospective study of 4020   Aractingi  S,  Chosidow  O.  Cutaneous  graft-versus-host  disease.
                                                  patients. J Am Acad Dermatol. 1993;29:228-236.  Arch Dermatol. 1998;134:602-612.
       Section 3: Malignant Growths              Mendenhall WM, Mendenhall CM, Werning JW, et al. Cutaneous   Araki  K,  Sudo  A,  Hasegawa  M,  et  al.  Devastating  ochronotic
       Abrams TA, Schuetze SM. Targeted therapy for dermatofibrosar-  angiosarcoma. Am J Clin Oncol. 2006;29:524-528.  arthropathy with successful bilateral hip and knee arthroplasties.
        coma protuberans. Curr Oncol Rep. 2006;8:291-296.  Ming M, He YY. PTEN: new insights into its regulation and func-  J Clin Rheumatol. 2009;15:138-140.
       Aydin F, Senturk N, Sabanciler MT, et al. A case of Ferguson-Smith   tion in skin cancer. J Invest Dermatol. 2009;129:2109-2112.  Arias-Santiago  S,  Aneiros-Fernandez  J,  Girón-Prieto  MS,  et  al.
        type  multiple  keratoacanthomas  associated  with  keratoacan-  Minicozzi A, Borzellino G, Momo R, et al. Perianal Paget’s disease:   Palpable purpura. Cleve Clin J Med. 2010;77:205-206.
        thoma centrifugum marginatum: response to oral acitretin. Clin   presentation of six cases and literature review. Int J Colorectal Dis.   Auerbach PS, ed. Wilderness Medicine. 5th ed. Philadelphia: Mosby;
        Exp Dermatol. 2007;32:683-686.            2010;25:1-7.                              2007:1262-1286.
       Bhawan J. Squamous cell carcinoma in situ in skin: what does it   Murphy  GF.  Dermatopathology.  Philadelphia:  Saunders;  1995:  Ayangco L, Rogers RS 3rd. Oral manifestations of erythema mul-
        mean? J Cutan Pathol. 2007;34:953-955.    192-194.                                  tiforme. Dermatol Clin. 2003;21:195-205.
       Black  APB,  Ogg  GS.  The  role  of  p53  in  the  immunobiology  of   Ntomouchtsis A, Vahtsesevanos K, Patrikidou A, et al. Adnexal skin   Badea I, Taylor M, Rosenberg A, et al. Pathogenesis and therapeutic
        cutaneous  squamous  cell  carcinoma.  Clin  Exp  Immunol.  2003;  carcinomas of the face. J Craniofac Surg. 2009;20:134-137.  approaches  for  improved  topical  treatment  in  localized  sclero-
        132:379-384.                             Odom  RB,  James  WB,  Berger  TG.  Andrews’  Disease  of  the  Skin:   derma and systemic sclerosis. Rheumatology. 2009;48:213-221.
       Bleeker MCG, Heideman DAM, Snijders PJF, et al. Penile cancer:   Clinical  Dermatology.  9th  ed.  Philadelphia:  Saunders;  2000:  Bandino JP, Wohltmann WE, Bray DW, et al. Naproxen-induced
        epidemiology,  pathogenesis  and  prevention.  World  J  Urol.   756-760.           generalized  bullous  fixed  drug  eruption.  Dermatol  Online  J.
        2009;27:141-150.                         Paradisi A, Abeni D, Rusciani A, et al. Dermatofibrosarcoma pro-  2009;15:4.
       Bongiorno MR, Doukaki S, Ferro G, et al. Matrix metalloprotein-  tuberans:  wide  local  excision  vs.  mohs  micrographic  surgery.   Banikazemi M, Bultas J, Waldek S, et al. Agalsidase-beta therapy
        ases 2 and 9, and extracellular matrix in Kaposi’s sarcoma. Der-  Cancer Treat Rev. 2008;34:728-736.  for advanced Fabry disease: a randomized trial. Ann Intern Med.
        matol Ther. 2010;23:S33-S36.             Richter ON, Petrow W, Wardelmann E, et al. Bowenoid papulosis   2007;146:77-86.
       Budd GT. Management of angiosarcoma. Curr Oncol Rep. 2002;4:  of  the  vulva—immunotherapeutical  approach  with  topical   Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous masto-
        515-519.                                  imiquimod. Arch Gynecol Obstet. 2003;268:333-336.  cytosis:  a  review  of  180  patients.  Isr  Med  Assoc  J.  2005;7:
       Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquer-  Rigel  DS,  Friedman  RJ,  Dzubow  LM,  et  al.  Cancer  of  the  Skin.   320-322.
        ader:  emerging  concepts  in  diagnosis  and  treatment.  Dermatol   Philadelphia: Saunders; 2005.  Ben Rayana N, Chahed N, Khochtali S, et al. Ocular ochronosis.
        Ther. 2008;21:459-466.                   Riou-Gotta MO, Fournier E, Danzon A, et al. Rare skin cancer: a   A case report. J Fr Ophtalmol. 2008;31:624.
       Catena F, Santini D, Di Saverio S, et al. Skin angiosarcoma arising   population-based cancer  registry  descriptive  study  of  151  con-  Bernier J, Booner J, Vermorken JB, et al. Consensus guidelines for
        in an irradiated breast: case-report and literature review. Derma-  secutive  cases  diagnosed  between  1980  and  2004.  Acta  Oncol.   the management of radiation dermatitis and co-existing acne-like
        tol Surg. 2006;32:447-455.                2009;48:605-609.                          rash in patients receiving radiotherapy plus EGRF inhibitors for
       Cox  NH,  Eedy  DJ,  Morton  CA.  Guidelines  for  management  of   Schwartz RA, Bridges TM, Butani AK, et al. Actinic keratosis: an   the treatment of squamous cell carcinoma of the head and neck.
        Bowen’s disease: 2006 update. Br J Dermatol. 2007;156:11-21.  occupational and environmental disorder. J Eur Acad Dermatol   Ann Oncol. 2008;19:142-149.
       Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratosis:   Venereol. 2008;22:606-615.  Bieber T, Novak N. Pathogenesis of atopic dermatitis: new devel-
        natural history and risk of malignant transformation in the Vet-  Shalin SC, Lyle S, Calonje E, et al. Sebaceous neoplasia and the   opments. Curr Allergy Asthma Rep. 2009;9:291-294.
        erans Affairs Topical Tretinoin Chemoprevention Trial. Cancer.   Muir-Torre  syndrome:  important  connections  with  clinical   Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and
        2009;115:2523-2530.                       implications. Histopathology. 2010;56:133-147.  soft-tissue infections. Ann N Y Acad Sci. 2007;1111:411-421.
       DiLorenzo G. Update on classic Kaposi sarcoma therapy: new look   Tai P, Yu E, Assouline A, et al. Management of Merkel cell carci-  Boguniewicz M, Leung DY. Recent insights into atopic dermatitis
        at an old disease. Crit Rev Oncol/Hematol. 2008;68:242-249.  noma with emphasis on small primary tumors: a case series and   and  implications  for  management  of  infectious  complications.
       Dimitropoulos  VA.  Dermatofibrosarcoma  protuberans.  Dermatol   review  of  the  current  literature.  J  Drugs  Dermatol.  2010;9:  J Allergy Clin Immunol. 2010;125:4-13.
        Ther. 2008;21:447-451.                    105-110.                                 Boissan M, Feger F, Guillosson J, et al. c-Kit and c-kit mutations
       Donovan J. Review of the hair follicle origin hypothesis for basal   Telfer NR, Clover GB, Morton CA. Guidelines for the manage-  in mastocytosis and other hematological diseases. J Leukoc Biol.
        cell carcinoma. Dermatol Surg. 2009;35:1311-1323.  ment of basal cell carcinoma. Br J Dermatol. 2008;159:35-48.  2000;67:135-148.
       Dubina  M,  Goldenberg  G.  Viral-associated  nonmelanoma  skin   Vergilis-Kalner IJ, Kriseman Y, Goldberg LH. Keratoacanthomas:   Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. St. Louis:
        cancers: a review. Am J Dermatopathol. 2009;31:561-573.  overview  and  comparison  between  Houston  and  Minneapolis   Mosby; 2008.
       Duvic M, Donato M, Dabaja B, et al. Total skin electron beam and   experiences. J Drugs Dermatol. 2010;9:117-121.  Brahimi N, Routier E, Raison-Peyron N, et al. A three-year-anal-
        non-myeloablative allogeneic hematopoietic stem-cell transplan-  Weedon D. Skin Pathology. New York: Churchill Livingstone; 1997.  ysis of fixed drug eruptions in hospital settings in France. Eur J
        tation in advanced mycosis fungoides and Sezary syndrome J Clin   Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous   Dermatol. 2010;20:461-464.
        Oncol. 2010;28:2365-2372.                 cell carcinoma: an update. Dermatol Surg. 2007;33:885-899.  Bremec T, Demsar J, Luzar B, et al. Longstanding truncal hyper-
       Egmond SV, Hoedemaker C, Sinclair R. Successful treatment of   Wood AJ, Lappinga PJ, Ahmed I. Hepatocellular carcinoma meta-  pigmented patches in a young man. Multiple fixed drug eruption
        perianal  Bowen’s  disease:  imiquimod.  Int  J  Dermatol.  2007;46:  static to skin: diagnostic utility of antihuman hepatocyte antibody   caused by acetaminophen. Clin Exp Dermatol. 2010;35:e56-e57.
        318-319.                                  in  combination  with  albumin  in  situ  hybridization.  J  Cutan   Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans
       Eisen DB, Michael DJ. Sebaceous lesions and their associated syn-  Pathol. 2009;36:262-266.  identifies  youth  at  high  risk  for  metabolic  abnormalities.  J
        dromes: part I. J Am Acad Dermatol. 2009;61:549-560.  Wu  XS,  Lonsdorf  AS,  Hwang  ST.  Cutaneous  T-cell  lymphoma:   Pediatr. 2010;156:87-92.
       Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimat-  roles for chemokines and chemokine receptors. J Invest Dermatol.   Briley LD, Phillips CM. Cutaneous mastocytosis: a review focusing
        ing  survival  and  recurrence  risk  based  on  histopathologic  fea-  2009;129:1115-1119.  on  the  pediatric  population.  Clin  Pediatr  (Phila).  2008;47:
        tures. Dermatol Ther. 2005;18:369-385.   Yu F, Finn DT, Rogers GS. Microcystic adnexal carcinoma: a rare   757-761.
       Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev   locally  aggressive  cutaneous  tumor.  Am  J  Clin  Oncol.  2010:33:  Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am.
        Cancer. 2008;8:743-754.                   196-197.                                  2004;24:287-316.
       Gaertner WB, Hagerman GF, Goldberg SM, et al. Perianal Paget’s   Yu  W,  Tsoukas  MM,  Chapman  SM,  et  al.  Surgical  treatment  of   Buck T, González LM, Lambert WC, et al. Sweet’s syndrome with
        disease  treated  with  wide  excision  and  gluteal  skin  flap  recon-  dermatofibrosarcoma  protuberans:  the  Dartmouth  experience   hematologic disorders: a review and reappraisal. Int J Dermatol.
        struction: report of a case and review of the literature. Dis Colon   and literature review. Ann Plastic Surg. 2008;60:288-293.  2008;47:775-782.
        Rectum. 2008;51:1842-1845.               Zinzani PL, Ferreri AJM, Cerroni L. Mycosis fungoides. Crit Rev   Burrall B. Sweet’s syndrome (acute neutrophilic febrile dermatosis).
       Grange JM, Krone B, Stanford JL. Immunotherapy for malignant   Oncol/Hematol. 2008;65:172-182.  Dermatol Online J. 1999;5:8.
        melanoma—tracing Ariadne’s thread through the labyrinth. Eur   Zwenzner EM, Kaatz M, Ziemer M. Skin metastasis of ‘nested type’   Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of
        J Cancer. 2009;45:2266-2273.              of urothelial carcinoma of the urinary bladder. J Cutan Pathol.   neonatal lupus erythematosus: guidelines to management, inte-
       Gremel G, Rafferty M, Lau TY, et al. Identification and functional   2006;33:754-755.  grating clues from the bench and bedside. Nat Clin Pract Rheu-
        validation of therapeutic targets for  malignant melanoma.  Crit                    matol. 2009;5:139-148.
        Rev Oncol/Hematol. 2009;72:194-214.      Section 4: Rashes                         Camelo-Piragua S, Zambrano E, Pantanowitz L. Langerhans cell
       Han A, Ratner D. What is the role of adjuvant radiotherapy in the   Abla  O,  Egeler  RM,  Weitzman  S.  Langerhans  cell  histiocytosis:   histiocytosis. Ear Nose Throat J. 2010;89:112-113.
        treatment of cutaneous squamous cell carcinoma with perineural   current  concepts  and  treatments.  Cancer  Treat  Rev.  2010;36:  Cario H, McMullin MF, Pahl HL. Clinical and hematological pre-
        invasion? Cancer. 2007;109:1053-1059.     354-359.                                  sentation  of  children  and  adolescents  with  polycythemia  vera.
       Houben  R,  Schrama  D,  Becker  JC.  Molecular  pathogenesis  of   Ahdout J, Haley JC, Chiu MW. Erythema multiforme during anti-  Ann Hematol. 2009;88:713-719.
        Merkel cell carcinoma. Exp Dermatol. 2009;18:193-198.  tumor necrosis factor treatment for plaque psoriasis. J Am Acad   Carlson  JA.  The  histological  assessment  of  cutaneous  vasculitis.
       Ivan D, Diwan AH, Lazar AJF, et al. The usefulness of p63 detec-  Dermatol. 2010;62:874-879.  Histopathology. 2010;56:3-23.
        tion for differentiating primary from metastatic skin adenocarci-  Ahmadi  S,  Powell  FC.  Pruritic  urticarial  papules  and  plaques  of   Chang  HY,  Ridky  TW,  Kimball  AB,  et  al.  Eruptive  xanthomas
        nomas. J Cutan Pathol. 2008;35:880-881.   pregnancy: current status. Australas J Dermatol. 2005;46:53-58.  associated  with  olanzapine  use.  Arch  Dermatol.  2003;139:
       Jones B, Oh C, Mangold E, et al. Muir-Torre syndrome: diagnostic   Akin C, Valent P, Escribano L. Urticaria pigmentosa and mastocy-  1045-1048.
        and screening guidelines. Aust J Dermatol. 2006;47:266-269.  tosis: the role of immunophenotyping in diagnosis and determin-  Chang KL, Snyder DS. Langerhans cell histiocytosis. Cancer Treat
       Kaehler KC, Sondak VK, Schadendorf D, et al. Pegylated interfer-  ing  response  to  treatment.  Curr  Allergy  Asthma  Rep.  2006;6:  Res. 2008;142:383-398.
        ons: prospects for the use in the adjuvant and palliative therapy   282-288.       Chassaing N, Martin L, Calvas P, et al. Pseudoxanthoma elasticum:
        of metastatic melanoma. Eur J Cancer. 2010;46:41-46.  Al Hammadi A, Asai Y, Patt ML, et al. Erythema annulare centrifu-  a  clinical,  pathophysiological  and  genetic  update  including  11
       Kanitakis  J.  Mammary  and  extramammary  Paget’s  disease.  J  Eur   gum secondary to treatment with finasteride. J Drugs Dermatol.   novel ABCC6 mutations. J Med Genet. 2005;42:881-892.
        Acad Dermatol Venereol. 2007;21:581-590.  2007;6:460-463.                          Chen YJ, Wu CY, Huang YL, et al. Cancer risks of dermatomyositis
       Kirkwood JM, Jukic DM, Averbook BJ, et al. Melanoma in pediat-  Ale IS, Maibacht HA. Diagnostic approach in allergic and irritant   and polymyositis: a nationwide cohort study in Taiwan. Arthritis
        ric, adolescent and young adults. Semin Oncol. 2009;36:419-431.  contact dermatitis. Expert Rev Clin Immunol. 2010;6:291-310.  Res Ther. 2010;12:R70.
       242                                                                                   THE NETTER COLLECTION OF MEDICAL ILLUSTRATIONS
   251   252   253   254   255   256   257   258   259   260   261